Page 51 - Read Online
P. 51
Page 4 of 4 Gilheeney. Rare Dis Orphan Drugs J. 2026;5:15
None.
Conflicts of interest
The author declared that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2026.
REFERENCES
1. Jones JM. LGBTQ+ Identification in U.S. Rises to 9.3%. Gallup. Available from: https://news.gallup.com/poll/656708/lgbtq-identificati
on-rises.aspx [Last accessed on 30 Apr 2026].
2. Endocrine society. Dosing standards for pubertal suppression and sex steroid hormones in transgender youth. 2020. Available from: https
://www.endocrine.org/-/media/endocrine/files/practice/gender_dosing_standards_transgender_youth.pdf [Last accessed on 22 Apr 2026].
3. Rosser T, Packer RJ. Neurofibromas in children with neurofibromatosis 1. J Child Neurol. 2002;17:585-91. DOI
4. Dagalakis U, Lodish M, Dombi E, et al. Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I. J
Pediatr. 2014;164:620-4. DOI
5. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine
society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:3869-903. DOI
6. Deutsch MB. Overview of masculinizing hormone therapy. UCSF Transgender Care & Treatment Guidelines. Available from: https://tra
nscare.ucsf.edu/guidelines/masculinizing-therapy [Last accessed on 22 Apr 2026].
7. Pennanen P, Peltonen S, Kallionpää RA, Peltonen J. The effect of estradiol, testosterone, and human chorionic gonadotropin on the
proliferation of Schwann cells with NF1 or NF1 genotype derived from human cutaneous neurofibromas. Mol Cell Biochem.
-/-
+/-
2018;444:27-33. DOI
8. Bubley JA, Yeung H, Cole E, Amin M, Parker D, Arbiser JL. Angiofibroma stimulation in a transgender person receiving
gender-affirming testosterone. JAAD Case Rep. 2020;6:1101-3. DOI
9. Herman JL, Flores AR, O’Neill KK. How many adults and youth identify as transgender in the United States? The Williams Institute,
UCLA School of Law. 2022. Available from: https://williamsinstitute.law.ucla.edu/wp-content/uploads/Trans-Pop-Update-Jun-2022.pdf
[Last accessed on 22 Apr 2026].
Disclaimer/Publisher’s Note: All statements, opinions, and data contained in this publication are solely those of the individual author(s) and
contributor(s) and do not necessarily reflect those of OAE and/or the editor(s). OAE and/or the editor(s) disclaim any responsibility for harm to
persons or property resulting from the use of any ideas, methods, instructions, or products mentioned in the content.
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and
reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons license, and indicate if changes were made.

